Skip to main content Accessibility help
×
Home

25-Hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese

  • Raymond YH Leung (a1) (a2), Bernard MY Cheung (a1), Kathryn CB Tan (a2), Annie WC Kung (a2) and Ching-Lung Cheung (a1) (a3)...

Abstract

Objective:

To investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) and risk of incident diabetes in Hong Kong Chinese, after accounting for the effect of multiple bone- and mineral-related markers.

Design:

We conducted a retrospective study on the Hong Kong Osteoporosis Study cohort. Incident diabetes was ascertained using electronic medical records. Serum 25(OH)D was measured at baseline and its association with incident diabetes was evaluated using multivariable Cox proportional-hazard regression.

Participants:

Individuals (n 4342) aged 20 years or above (1395 men, 2947 women; mean age 54·3 (sd 16·5) years) from the Hong Kong Osteoporosis Study, who were free of diabetes at baseline, were included.

Results:

During 40 124·7 person-years of follow-up (a median of 9·2 years), 443 participants developed diabetes. Mean 25(OH)D was 63·34 (sd 13·07) nmol/l. Age-, sex- and BMI-adjusted Cox proportional-hazard regression showed no significant difference in the risk of incident diabetes between the lowest and the highest quintiles of 25(OH)D. In the analysis of the interaction effect between 25(OH)D and serum Ca, the interaction term did not affect the risk of incident diabetes significantly (P = 0·694). Similarly, there was no significant interaction of different subgroups (age, sex, BMI, femoral-neck T-score, serum Ca levels) with serum 25(OH)D.

Conclusions:

The present study finds that serum vitamin D level is not associated with the risk of incident diabetes in Hong Kong Chinese and this relationship is not modified by serum Ca level.

Copyright

Corresponding author

*Corresponding author: Email lung1212@hku.hk

References

Hide All
1.Hossein-nezhad, A & Holick, MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88, 720755.
2.Leung, RY, Cheung, BM, Nguyen, U-S et al. (2017) Optimal vitamin D status and its relationship with bone and mineral metabolism in Hong Kong Chinese. Bone 97, 293298.
3.Holick, MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 6 Suppl., 1678S1688S.
4.Forman, JP, Giovannucci, E, Holmes, MD et al. (2007) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49, 10631069.
5.Forouhi, NG, Luan, J, Cooper, A et al. (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57, 26192625.
6.Judd, SE, Morgan, CJ, Panwar, B et al. (2016) Vitamin D deficiency and incident stroke risk in community-living black and white adults. Int J Stroke 11, 93102.
7.Afzal, S, Brøndum-Jacobsen, P, Bojesen, SE et al. (2014) Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol 2, 298306.
8.Norman, AW, Frankel, J, Heldt, AM et al. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209, 823825.
9.Cade, C & Norman, AW (1986) Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119, 8490.
10.Cade, C & Norman, AW (1987) Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120, 14901497.
11.Chiu, KC, Chu, A, VLW, Go et al. (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79, 820825.
12.Kramer, CK, Swaminathan, B, Hanley, AJ et al. (2014) Prospective associations of vitamin D status with β-cell function, insulin sensitivity, and glycemia: the impact of parathyroid hormone status. Diabetes 63, 38683879.
13.Pittas, AG, Dawson-Hughes, B, Li, T et al. (2006) Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650656.
14.Knekt, P, Laaksonen, M, Mattila, C et al. (2008) Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19, 666671.
15.Grimnes, G, Emaus, N, Joakimsen, R et al. (2010) Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med 27, 11071115.
16.Yiu, Y-F, Chan, Y-H, Yiu, K-H et al. (2011) Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 96, E830E835.
17.Yiu, Y-F, Yiu, K-H, Siu, C-W et al. (2013) Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227, 140146.
18.Sing, C, Cheng, V, Ho, D et al. (2016) Serum calcium and incident diabetes: an observational study and meta-analysis. Osteoporos Int 27, 17471754.
19.Rooney, MR, Pankow, JS, Sibley, SD et al. (2016) Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr 104, 10231029.
20.Cheung, C-L, Sham, PC, Chan, V et al. (2008) Identification of LTBP2 on chromosome 14q as a novel candidate gene for bone mineral density variation and fracture risk association. J Clin Endocrinol Metab 93, 44484455.
21.Cheung, C-L, Tan, KC & Kung, AW (2017) Cohort profile: the Hong Kong Osteoporosis Study and the follow-up study. Int J Epidemiol 47, 397f398f.
22.So, J, Tang, W, Leung, WK et al. (2017) Cancer risk in 2621 Chinese patients with inflammatory bowel disease: a population-based cohort study. Inflamm Bowel Dis 23, 20612068.
23.Chan, EW, Lau, WC, Leung, WK et al. (2015) Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology 149, 586595.e3.
24.Stepman, HC, Vanderroost, A, Van Uytfanghe, K et al. (2011) Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope dilution–liquid chromatography–tandem mass spectrometry. Clin Chem 57, 441448.
25.Mineva, EM, Schleicher, RL, Chaudhary-Webb, M et al. (2015) A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 using isotope-dilution liquid chromatography–tandem mass spectrometry. Anal Bioanal Chem 407, 56155624.
26.Leslie, WD, Rubin, MR, Schwartz, AV et al. (2012) Type 2 diabetes and bone. J Bone Miner Res 27, 22312237.
27.Bischoff-Ferrari, HA, Giovannucci, E, Willett, WC et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 1828.
28.Boucher, B, Mannan, N, Noonan, K et al. (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38, 12391245.
29.Kayaniyil, S, Retnakaran, R, Harris, SB et al. (2011) Prospective associations of vitamin D with β-cell function and glycemia. Diabetes 60, 29472953.
30.Maestro, B, Campión, J, Dávila, N et al. (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383391.
31.Fadda, GZ, Akmal, M, Lipson, L et al. (1990) Direct effect of parathyroid hormone on insulin secretion from pancreatic islets. Am J Physiol 258, E975E984.
32.Soric, MM, Renner, ET & Smith, SR (2012) Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled type 2 diabetes mellitus: a pilot study. J Diabetes 4, 104105.
33.Krul-Poel, YH, Westra, S, ten Boekel, E et al. (2015) Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY trial): a randomized placebo-controlled trial. Diabetes Care 38, 14201426.
34.Lucato, P, Solmi, M, Maggi, S et al. (2017) Low vitamin D levels increase the risk of type 2 diabetes in older adults: a systematic review and meta-analysis. Maturitas 100, 815.
35.Afzal, S, Bojesen, SE & Nordestgaard, BG (2013) Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 59, 381391.
36.Kirii, K, Mizoue, T, Iso, H et al. (2009) Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52, 25422550.
37.Napoli, N, Schafer, AL, Lui, L-Y et al. (2016) Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the Osteoporotic Fractures in Men (MrOS) study. Bone 90, 181184.
38.Schafer, A, Napoli, N, Lui, L et al. (2014) Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women. Diabet Med 31, 564569.
39.Robinson, JG, Manson, JE, Larson, J et al. (2011) Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 34, 628634.
40.Seida, JC, Mitri, J, Colmers, IN et al. (2014) Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 99, 3551.
41.Moreira-Lucas, TS, Duncan, AM, Rabasa-Lhoret, R et al. (2017) Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): a double-blind, randomized, placebo-controlled clinical trial. Diabetes Obes Metab 19, 133141.
42.Thomas, GN, Scragg, R, Jiang, CQ et al. (2012) Hyperglycaemia and vitamin D: a systematic overview. Curr Diabetes Rev 8, 1831.
43.Liu, S, Song, Y, Ford, ES et al. (2005) Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 28, 29262932.
44.Liu, E, Meigs, JB, Pittas, AG et al. (2010) Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin Nutr 91, 16271633.
45.Schöttker, B, Herder, C, Rothenbacher, D et al. (2013) Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol 28, 267275.
46.Pittas, AG, Sun, Q, Manson, JE et al. (2010) Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 33, 20212023.
47.Thorand, B, Zierer, A, Huth, C et al. (2011) Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation. Diabetes Care 34, 23202322.
48.Krul-Poel, YH, Ter Wee, MM, Lips, P et al. (2016) Management of endocrine disease: the effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Eur J Endocrinol 176, R1R14.
49.Jorde, R, Sollid, ST, Svartberg, J et al. (2016) Vitamin D 20 000 IU per week for five years does not prevent progression from prediabetes to diabetes. J Clin Endocrinol Metab 101, 16471655.
50.Fuleihan, GE-H, Baddoura, R, Habib, RH et al. (2016) Effect of vitamin D replacement on indexes of insulin resistance in overweight elderly individuals: a randomized controlled trial. Am J Clin Nutr 104, 315323.
51.Heijboer, AC, Blankenstein, MA, Kema, IP et al. (2012) Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 58, 543548.

Keywords

Type Description Title
WORD
Supplementary materials

Leung et al. supplementary material
Tables S1-S3

 Word (40 KB)
40 KB

25-Hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese

  • Raymond YH Leung (a1) (a2), Bernard MY Cheung (a1), Kathryn CB Tan (a2), Annie WC Kung (a2) and Ching-Lung Cheung (a1) (a3)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed